Wednesday, September 18, 2013

Fitness in Middle Age May Help Shield Men From Cancer Later

News Picture: Fitness in Middle Age May Help Shield Men From Cancer LaterBy Kathleen Doheny
HealthDay Reporter

THURSDAY, May 16 (HealthDay News) -- Men who are physically fit in middle age have a lower risk of developing and dying from certain cancers, new research indicates.

"Fitness is a huge predictor of [cancer] risk," said Dr. Susan Lakoski, an assistant professor of internal medicine at the University of Vermont, in Burlington. "You need to be fit to protect yourself against a cancer diagnosis in older age."

Men who were fit in their 40s, 50s and 60s were less likely decades later to get lung or colorectal cancer, she found. Those who were fit were also less likely to die from prostate, lung or colorectal cancers.

She is scheduled to present her research, supported by the U.S. National Cancer Institute, on June 2 at the American Society of Clinical Oncology annual meeting in Chicago.

While other studies have found physical activity protects against certain cancers, Lakoski said fewer studies have looked at the importance of fitness to predict whether men would develop or die from cancers.

For the study, Lakoski and her colleagues evaluated more than 17,000 men who had a single cardiovascular fitness assessment as part of a preventive health checkup at the Cooper Clinic, in Dallas, when they were 50, on average.

The men walked on a treadmill under a regimen of changing speed and incline. Their results were categorized into five groups, from lowest fitness level to highest.

Later on, the researchers analyzed Medicare claims data to identify the participants who had developed three common cancers among U.S. men -- lung, colorectal or prostate.

The average follow-up period was 20 to 25 years. During that time, 2,332 men developed prostate cancer, 276 developed colorectal cancer and 277 developed lung cancer.

During the follow up, 769 men died -- 347 of cancer, 159 of heart disease and 263 of other causes.

The men who were most fit on the treadmill test, when compared to the least, had a 68 percent lower risk of lung cancer and a 38 percent lower risk of colorectal cancer. Their prostate cancer risk didn't decline with increasing fitness, but the risk of death from it did.

Even a small improvement in fitness helped, the researchers found. For instance, a 50-year-old man who increased fitness so he could last three more minutes on the treadmill, Lakoski said, could reduce cancer death risk by 14 percent and heart disease death risk by 23 percent.

Low fitness levels increased the risk of cancer and heart disease even in men who weren't obese, the researchers found.

They also took into account other factors that could increase risk, such as age and smoking habits.

The good news, Lakoski said, is that, "You don't have to be highly fit to get protection." The most protection against cancer and heart disease was found in moving out of the least fit group.

And how unfit were those men? The men in the least fit group who were 40 to 49 when they took the test could walk on the treadmill less than 13.5 minutes. Those who were 50 to 59 lasted less than 11 minutes. Those 60 and older in the least fit group only lasted less than 7.5 minutes.

The findings make sense, said Colleen Doyle, director of nutrition and physical activity for the American Cancer Society.

"While you can't tell just how much activity these guys were doing over time, it makes sense that the most fit would have better cancer-related outcomes -- because they are likely the most active." While the new research did not find a link between fitness levels and a diagnosis of prostate cancer, a recent review of other published studies did show a modest reduction in that risk, Doyle said.

Lakoski can't explain the protective effects of fitness for sure, but can speculate. "We know that fitness modulates several important pathways also related to cancer risk," she said. These include, among other pathways, reducing inflammation and oxidative damage in the cells, she said.

Doyle agreed that many mechanisms are probably at work. Activity can improve immune function, for instance, and help control weight, and that in turn can decrease inflammation, she said.

To achieve cardiovascular fitness and reduce cancer risk, be moderately active 150 minutes a week or vigorously active for 75 minutes, or some combination, Doyle advised.

Because this study is being presented at a medical meeting, the data and conclusions should be viewed as preliminary until published in a peer-reviewed journal.

Lakoski found a link between fitness and cancer protection, not cause and effect. She also can't say whether the findings would apply to women. She hopes to study that next.

MedicalNews
Copyright © 2013 HealthDay. All rights reserved. SOURCES: Susan Lakoski, M.D., assistant professor, internal medicine, University of Vermont, Burlington; Colleen Doyle, M.S., R.D., director, nutrition and physical activity, American Cancer Society; June 2, 2013, presentation, American Society of Clinical Oncology annual meeting, Chicago



View the original article here

Tuesday, September 17, 2013

SAHM and in need of some motivation!

So I'm a SAHM of a very busy 9 month old boy. I don't have a vehicle during the day so most days I stay in my pj's since I don't go anywhere. I need halo staying motivated to track what I eat to keep from constantly snacking and over eating. I want to lose this baby weight!

View the original article here

Some Types of Skin Cancer Linked to Lower Chances of Alzheimer's

A weak immune response might allow skin cancer but protect brain from inflammation, expert suggestsLarge study found higher rates of squamous cell,

By Barbara Bronson Gray

HealthDay Reporter

WEDNESDAY, May 15 (HealthDay News) -- There's some good news for people who have had certain kinds of skin cancer: A new study suggests that their odds of developing Alzheimer's disease may be significantly lower than it is for others.

People who had non-melanoma skin cancer were nearly 80 percent less likely to develop Alzheimer's disease than people who did not. The association was not found with other types of dementia.

To understand the possible association between skin cancer and Alzheimer's, it is important to know that people have a combination of cells that are multiplying and others that are dying, explained study author Dr. Richard Lipton, a professor of neurology, epidemiology and population health at the Albert Einstein College of Medicine in New York City. The research was published online May 15 in the journal Neurology.

"When cell division gets out of control, we call that cancer. And when specific populations of brain cells die, we call that Alzheimer's," Lipton said. "So, there is a balance between cell division [growth] and cell death. If you have an individual with an increased risk of cell division over cell death, that may be linked to a decreased risk of Alzheimer's."

The finding was intriguing to one expert.

"It's fascinating that we can get clues about what's going on in the brain by looking at the periphery [skin]," said Terrence Town, a professor in the physiology and biophysics department at the Keck School of Medicine at the University of Southern California.

Non-melanoma skin cancer is the most common cancer in the United States; there were more than 2 million new cases in 2012, according to the U.S. National Cancer Institute.

What could be causing the possible association between skin cancer and a reduced risk of Alzheimer's?

"Either developing skin cancer is a marker for some biological process that protects against Alzheimer's or environmental factors may play a role," Lipton said. Genetics could be a factor, as could lots of outdoor physical activity and exercise, although Lipton cautioned people to avoid too much sun exposure and wear sunscreen.

Others think the link may be directly related to how the lowered immune response of skin cells in skin cancer corresponds to a similar immune response in the brain.

"This research is another piece of evidence that tells us that peripheral inflammation [in the skin] is very important in Alzheimer's disease," Town said. He thinks that people who develop non-melanoma skin cancers don't have an immune response in their skin, and thus develop skin cancers, because an immune response may be critical to fighting skin cancer. But that benefits them when it comes to developing Alzheimer's disease.

"This reduced inflammatory response that was permissive to the skin cancer was perhaps beneficial in the brain," said Town.


View the original article here

Migraine Sufferers Face Significant Stigma, Study Finds

Equal to that for epilepsy, panic disorder, researchers say, with impact of the disability discountedIn research involving patients with migraine with

By Kathleen Doheny

HealthDay Reporter

THURSDAY, June 27 (HealthDay News) -- Those who get migraines have to deal not only with the pain, which can be disabling, but the stigma caused by others who tend to discount the impact of the debilitating headaches, a new study shows.

"We were able to validate that people who have migraine are not mistaken that they feel they are stigmatized," said lead researcher Dr. Robert Shapiro, a professor of neurological sciences at the University of Vermont College of Medicine. "We have found those perceptions are well-grounded, and that the stigma that people with migraine experience is of a similar magnitude to the stigma people with epilepsy and panic attack experience," he noted.

"The general attitude is that migraine is not a serious or valid condition," he said. In the study, those with asthma experienced the least amount of stigma of the four conditions studied. Epilepsy patients can experience unpredictable seizures and the condition is known to carry a stigma. Panic attacks, where sufferers experience bouts of intense fear, are also unpredictable.

Shapiro is due to present the findings Sunday at the International Headache Congress in Boston.

About 29.5 million Americans are affected by migraine pain and symptoms, according to the U.S. Department of Health and Human Services. Symptoms can include severe headache, light sensitivity and nausea. Those who are affected may need bed rest and may be unable to work while they are experiencing a migraine.

Shapiro polled 765 people online. All were U.S. residents, with an average age of 28. When presented with vignettes that described people with asthma, migraine, panic attack and epilepsy, the survey participants answered questions on a well-known test used to assess stigma towards illness.

The questionnaire, Shapiro explained, "just provides insight into how someone wants to be associated with someone else." For instance, respondents told how likely they were to want to work with someone with one of the four conditions, and how comfortable they would be inviting them to a dinner party.

The lowest stigma score was for those with asthma. "What we found was the score for migraine versus epilepsy versus panic attack were quite close together and quite similar," Shapiro said.

The study was funded by the Canadian Institutes of Health Research. Peter Reiner, of the University of British Columbia, also conducted the research.

Some of Shapiro's findings echo those from another study, published earlier this year, in which researchers from Thomas Jefferson University Hospital's Headache Center found that chronic migraine patients experienced more stigma than did those with epilepsy, while those with episodic migraines experienced less stigma than those with chronic migraines.

The latest finding did not surprise Dr. Randall Berliner, a neurologist and psychiatrist specializing in headache disorders at Lenox Hill Hospital in New York City.


View the original article here

Simponi Approved for Ulcerative Colitis

WEDNESDAY, May 15 (HealthDay News) -- Simponi (golimumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with moderate-to-severe ulcerative colitis.

The drug is designed to block tumor necrosis factor, which has a key role in causing abnormal inflammation and immune system responses, the FDA said Wednesday in a news release.

The drug has already been approved to treat psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis, the agency said.

Ulcerative colitis, affecting some 620,000 Americans, causes chronic inflammation and ulcers in the inner lining of the large intestine. Common symptoms include abdominal discomfort, gastrointestinal bleeding and diarrhea.

Simponi was clinically evaluated in two studies involving more than 800 people. The most common side effects reported were upper respiratory infection and redness at the injection site. People treated with the drug are at greater-than-average risk of contracting several types of infection, lymphoma, heart failure, nervous system disorders and allergic reactions, the FDA said.

The drug is marketed by Janssen Ortho Biotech Inc., based in Horsham, Pa.

-- Scott Roberts MedicalNews
Copyright © 2013 HealthDay. All rights reserved.



View the original article here

National Bike to Work Day is Tomorrow, So Here Are Some Tips and Tools to Ride Like a Pro

National Bike to Work Day Tips and Tricks

Tomorrow is Bike to Work Day! Will you be strapping on your helmet and hitting the road with your fellow two-wheeled commuters? If you don't yet have a bike, we've got plenty of tips on helping you pick the right one. And if you just need some cool commuting swag to go with your already sweet ride, we've got that, too. Here are some great tips (and gear) for making your trip to and from the office safer, easier, and lots of fun.

Mount your phone. Want to listen to music while you ride? Earbuds are dangerous, and actually against the law in some cities. Need bike-friendly directions? Don't even try biking one-handed while you fiddle with your apps. Instead, use one of Biologic's water-resistant Bike Mounts ($40 - $50) to keep your iPhone or Android device securely on your handlebars while you ride. Blast tunes, follow turn-by-turn directions, or track your cycling stats with a bike computer app -- all hands-free.Wear street-smart shoes. We already told you about these flat-on-one-side bike pedals  that you flip to clip into. Today, we've got a pair of kicks that do double duty, too. Chrome's unisex Truk Pro shoes ($90) are casual Friday-friendly, and they contain a hidden SPD clip that stays totally out of the way (aka no annoying scraping on the sidewalk) when you're not on your bike. One less pair of shoes to lug to work? Score.Protect your calves. I pretty much walk around all summer with greasy black chain marks all over my right leg. Then again, I work from home. For those of you who need to look presentable on a daily basis, a FreeDrive Chain Cover ($20) can protect your legs (or your dress pants) from chain grease on any single-speed or multi-speed internal hub gear bike. Totes worth the twenty spot.Stay bright at night. You know you need a headlight and tail light if you're going to be riding after dark. (This one will work for commuters, as well as serious cyclists.) But you can make nighttime riding even safer with Ryde Safe's reflective bike decals ($13 for a medium pack) in several colors and designs. I mean, they even have mustaches -- how hipster chic, right?!?! Stick 'em all over, or follow the site's tutorials for making cool customized designs that are visible from any angle, at any time of day.Bring your bike bag to work. Riding with a backpack works most of the time, but when you're riding in work clothes on a hot day, you don't really want to get all sweaty back there. That's why Electra makes the Slimline Tote Bag ($99), which attaches easily to a rear bike racks but also transition seamlessly to the office.

What gear helps you handle a bike commute to work? Will you #BiketoWork tomorrow? Tweet us at @amandaemac and @SELFmagazine!

RELATED LINKS:

Image Credit: Thayer Allison Gowdy


View the original article here

what can eat so i wont get fat and loose my belly

Sorry, I could not read the content fromt this page.

View the original article here